Results 231 to 240 of about 344,438 (318)

From Glacial Refugia to Future Shifts: Unraveling the Spatiotemporal Dynamics of Endangered <i>Acer sutchuenense</i> Franch. Under Climate Change. [PDF]

Biology (Basel)
Xia X, Yang X, Li S, Xiang W, He L, Luo Z.   +5 more
europepmc   +1 more source

Understanding the potential uses of soil moisture information in the United States

Vadose Zone Journal, Volume 25, Issue 2, March/April 2026.
Abstract Soil moisture (SM) is an important component of the hydrological cycle that can impact runoff generation, evapotranspiration, crop growth, and wildfire behavior. Most studies, however, focus on technical aspects in a single sector, which makes it difficult to understand all of the current and potential benefits of SM information.
Riza Radmehr, B. Wade Brorsen, Erik S. Krueger, Tyson E. Ochsner   +3 more
wiley   +1 more source

Mallard response to experimental human disturbance on sanctuary areas is mediated by hunting

Wildlife Biology, Volume 2026, Issue 2, March 2026.
Wildlife managers often provide spatial sanctuaries for wildlife to escape both lethal (e.g. hunting) and non‐lethal (e.g. non‐consumptive recreation) human disturbance. However, as societal interest in outdoor recreation continues to climb, many areas face added pressure to allow recreation, yet studies increasingly demonstrate negative effects of ...
Abigail G. Blake‐Bradshaw, Nicholas M. Masto, Cory J. Highway, Allison C. Keever, Jamie C. Feddersen, Heath M. Hagy, Bradley S. Cohen   +6 more
wiley   +1 more source

Validation of the Norwegian version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale. [PDF]

Clin Park Relat Disord
Alves G, Sørenes YS, Frantzen VH, Gjerstad MD, Bjørnestad AL, Maple-Grødem J, Forsaa EB, Hiorth YH, Herlofson K, Benjaminsen E, Bjørnarå KA, Dietrichs E, Balestrino R, Gasca-Salas C, Lin CR, Sanchez-Ferro A, Tosin MHS, Mestre TA, Kurtis MM, Martinez-Martin P, Luo S, Yu L, Stebbins GT, Goetz CG, MDS COA Translation Steering Committee.   +24 more
europepmc   +1 more source

Navigating a landscape of contrasting hunting regimes and habitats: red deer responses to risk and resources

Wildlife Biology, Volume 2026, Issue 2, March 2026.
Habitat selection of ungulates is influenced by various factors, with human interactions playing a significant role. Human disturbances through hunting strongly affect ungulate behaviour, often forcing them to modify their habitat choices by avoiding areas where the risk from humans outweighs other habitat benefits. Gaining insights into these dynamics
Juliana Eggers, Michael Maroschek, Rupert Seidl, Sina Greiner, Matthias Loretto, Sebastian Seibold, Rudolf Reiner   +6 more
wiley   +1 more source

Is It Cold Enough? Effects of Artificial and Natural Chilling on Budbreak and Frost Hardiness in Acer saccharum (Marsh.). [PDF]

Physiol Plant
Mura C, Charrier G, Kovaleski AP, Raymond P, Deslauriers A, Rossi S.   +5 more
europepmc   +1 more source

Integrating fecal DNA and telemetry to estimate wildlife densities in anthropogenic landscapes

Wildlife Society Bulletin, Volume 50, Issue 1, March 2026.
Density estimation is central to wildlife management efforts but can be challenging in anthropogenic landscapes due to small parcel sizes, access restrictions, and limited green space. We evaluated (a) the use of a plot‐based spatial capture‐recapture sampling design to estimate deer density in developed landscapes and (b) if integrating telemetry data
Ashley Lynn, Mikiah McGinn, Nathan J. Hostetter, Heather Evans, Christopher E. Moorman, Nils Peterson, John Kilgo, Elizabeth M. Kierepka   +7 more
wiley   +1 more source

Correction: A social prescribing model for tackling the health and social inequalities of people living with severe mental illness: a protocol paper. [PDF]

BMC Public Health
Leavey G, Watterson R, McAnee G, Shannon S, Boyd K, Lloyd-Evans B, Killaspy H, Miller I, Whitaker P, Golden S, Boyd G, Ross L, Curran R, Wylie S, Breslin G, Davidson G.   +15 more
europepmc   +1 more source

Clinical Evaluation of Drug–Drug Interactions With Aficamten

Clinical and Translational Science, Volume 19, Issue 3, March 2026.
ABSTRACT Aficamten is a next‐in‐class small molecule cardiac myosin inhibitor that was recently approved by the United States Food and Drug Administration (FDA) for the treatment of symptomatic obstructive hypertrophic cardiomyopathy (oHCM). A comprehensive drug–drug interaction (DDI) evaluation of aficamten was achieved through two phase 1 studies in ...
Neha Maharao, Donghong Xu, Punag Divanji, Tyrell J. Simkins, Jianlin Li, Camelia Dumitrescu, Priyanka Solanki, Adrienne Griffith, Stephen B. Heitner, Stuart Kupfer, Polina German, Justin D. Lutz   +11 more
wiley   +1 more source

A unified concatenation model for plasma physics: Integrability and soliton solutions. [PDF]

MethodsX
Zayed EME, El-Shater M, Arnous AH, Biswas A.   +3 more
europepmc   +1 more source